SCHEMBL10341802

SCHEMBL10341802

NC(=O)NCc1ccccc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
CYP2C19 P33261 2/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
PTPN1 P18031 1/20 0.57
ALDH1A1 P00352 5/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
POLB P06746 1/20 0.52
LMNA P02545 1/20 0.52
TSHR P16473 1/20 0.51
KDM4E B2RXH2 1/20 0.51
CA12 O43570 1/20 0.50
CTSD P07339 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5237525 0.85 NPC1 (0.54) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL1252918 0.85 KMT2A (0.64) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL20511418 0.83 MEN1 (0.62) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL9700935 0.83 KMT2A (0.58) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL7592301 0.83 NPC1 (0.51) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL19246201 0.81 HPGD (0.64) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL9366252 0.81 ALDH1A1 (0.58) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL20495063 0.81 MEN1 (0.59) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL3957352 0.81 CYP2C19 (0.60) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL513780 0.81 PTPN1 (0.61) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0194226-A1 A pharmaceutical composition containing an imidazolidinetrione derivative or pharmaceutically acceptable salt thereof NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) 1986-09-10 EP claimed
EP-0194226-B1 A PHARMACEUTICAL COMPOSITION CONTAINING AN IMIDAZOLIDINETRIONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) 1990-02-07 EP disclosed
US-4683240-A HYPOGLYCEMIC, HYPOUPIDEMIC NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1987-07-28 US disclosed
EP-0194226-A1 A pharmaceutical composition containing an imidazolidinetrione derivative or pharmaceutically acceptable salt thereof NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) 1986-09-10 EP disclosed